Development
Bristol-Myers Squibb Company
BMY
$48.44
$0.631.32%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
--
EPS (TTM)
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -12.86% | 20.05% | 45.88% | 77.00% | -14.76% |
| Total Depreciation and Amortization | -1.10% | -7.44% | -3.54% | -7.52% | -7.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.33% | 111.08% | -632.03% | -250.60% | 20.76% |
| Change in Net Operating Assets | 286.68% | 77.44% | -8.07% | -275.69% | -676.27% |
| Cash from Operations | 28.61% | 28.86% | -16.54% | -22.09% | -18.51% |
| Capital Expenditure | 4.62% | -38.46% | 4.78% | -9.88% | -8.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -400.86% | 90.00% | 60.60% | 82.35% | 23.68% |
| Divestitures | -66.10% | 11.76% | 1.04% | 25.41% | 299.44% |
| Other Investing Activities | -170.12% | -99.09% | -131.01% | -113.30% | 38.71% |
| Cash from Investing | -210.96% | 80.30% | -13.84% | -321.05% | 202.49% |
| Total Debt Issued | 3,004.41% | 86.11% | 30.68% | -97.86% | -- |
| Total Debt Repaid | -- | 100.00% | 91.69% | 71.57% | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | -583.76% | -- | 95.00% | 12.18% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.31% | -3.21% | -4.09% | -0.93% | -4.19% |
| Other Financing Activities | -86.03% | -22.64% | -87.35% | -127.63% | 6,066.67% |
| Cash from Financing | 129.79% | -13.58% | 38.27% | 46.05% | 18.17% |
| Foreign Exchange rate Adjustments | -17.89% | 42.42% | 88.73% | 44.44% | 275.93% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 188.82% | 71.46% | 61.52% | 84.05% | 213.04% |